The MightySat Medical, a fingertip pulse oximeter, has become the first and currently the only medical device of its kind to be clared by the US Food and Drug Administration (FDA) for direct purchase by consumers, without needing a prescription.
This device, manufactured by Masimo, utilizes the same technology as many hospitals, making it a potential benefit for individuals with diagnosed breathing issues like asthma, COPD, or even COVID-19. According to Masimo, the device allows patients to collect accurate data on their blood oxygen levels and share it with their healthcare providers.
However, it’s important to note that pulse oximeters, in general, face challenges in terms of accuracy when measuring patients who are moving, have poor circulation, or have darker skin tones. Masimo claims their MightySat Medical addresses these issues and provides reliable readings for all patient groups.
The company further emphasizes the potential confusion caused by non-FDA-cleared pulse oximeters available over-the-counter. They believe this clearance provides healthcare professionals with more confidence when recommending the MightySat Medical to their patients.
While the device is intended for adults above 18, it’s crucial to remember that it is not a diagnostic tool and should not be used to diagnose or screen for lung diseases. Any treatment decisions based on readings from this device should only be made in consultation with a healthcare professional.
